PRKCD and breast carcinoma: Similarly to PKCα, the activation of PKCδ was related to growth inhibition of MCF-7 ATRA-sensitive breast cancer cell line [121], and the pharmacological inhibition of both PKCα and PKCδ impaired the RARs activation by ATRA in SKBR3 human mammary cell line [122].